These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 35269795)

  • 41. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Zinc status improving as a pathogenetically grounded platform for maintaining immunity during SARS-CoV-2 pandemic].
    Sankova MV; Kytko OV; Dydykina IS; Chilikov VV; Laptina VI; Markina AD
    Vopr Pitan; 2021; 90(2):26-39. PubMed ID: 34019346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.
    Luo J; Liang S; Jin F
    Sci China Life Sci; 2021 Jun; 64(6):942-956. PubMed ID: 33521857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2-specific virulence factors in COVID-19.
    Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
    J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.
    Liu C; Mu C; Zhang Q; Yang X; Yan H; Jiao H
    Med Sci Monit; 2021 Jul; 27():e930168. PubMed ID: 34193809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
    Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
    Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
    Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
    Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
    Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
    EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunomodulatory Role of Microelements in COVID-19 Outcome: a Relationship with Nutritional Status.
    Renata RN; Arely GA; Gabriela LA; Esther MM
    Biol Trace Elem Res; 2023 Apr; 201(4):1596-1614. PubMed ID: 35668151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
    Hu J; Zhang L; Lin W; Tang W; Chan FKL; Ng SC
    Trends Food Sci Technol; 2021 Feb; 108():187-196. PubMed ID: 33519087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiota and Its Impact on the Immune System in COVID-19-A Narrative Review.
    Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2.
    Sarkar A; Harty S; Moeller AH; Klein SL; Erdman SE; Friston KJ; Carmody RN
    Trends Mol Med; 2021 Dec; 27(12):1115-1134. PubMed ID: 34756546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview.
    Dellino M; Cascardi E; Vinciguerra M; Lamanna B; Malvasi A; Scacco S; Acquaviva S; Pinto V; Di Vagno G; Cormio G; De Luca R; Lafranceschina M; Cazzato G; Ingravallo G; Maiorano E; Resta L; Daniele A; La Forgia D
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.